Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-324446
Filing Date
2026-07-29
Accepted
2026-07-29 20:06:00
Documents
1
Period of Report
2026-07-28

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 5952
  Complete submission text file 0001193125-26-324446.txt   7380
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 500 SAN DIEGO CA
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 500 SAN DIEGO CA 858-704-4660
Viking Therapeutics, Inc. (Issuer) CIK: 0001607678 (see all company filings)

EIN.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O VIKING THERAPEUTICS, INC. 12340 EL CAMINO REAL, STE 250 SAN DIEGO CA 92130
Business Address
Mancini Marianna (Reporting) CIK: 0001838112 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37355 | Film No.: 261219745